Genomic abnormalities can lead to the potential development of tumors in patients and reduce the efficacy of MSC treatments (Neri, 2019). Traditional G-Banding karyotyping is helpful in providing an exhaustive structural and numerical variant analysis. However, it can be long and difficult to organize. This led Stem Genomics to develop a specific solution for research scientists working on hMSCs.
iCS-digital™ MSC has been designed to capture 80% of abnormalities found in MSCs.
We carried out an exhaustive meta-analysis of genomic abnormalities and referenced about 300 genetic abnormalities in hMSC lines. We then used this data to design our own assay: a set of 24 probes optimized to target all human chromosomes.
Our digital PCR-based solution enables rapid and cost-effective screening for chromosomal abnormalities, delivering results in just 3 days.
iCS-digital™ MSC can also complement a process already in place and bring an extra layer of precision to your QC.
During cell expansion
Cells in fresh culture media (or in cell culture supernatant)
>80% of recurrent abnormalities
>20% (depending on sample quality)
2-3 days after sample reception
Available as a service only
from one sample:
Recommended guidelines in terms of genomic stability advise checking the cells during their time in culture but also screening clones after any stressing process (reprogramming, gene editing, etc.) and during banking. It is also advisable when a new line is acquired.
Join us LIVE for our webinar “Genomic stability made easy” to discover how Stem Genomics has turned cutting-edge technologies into easy testing solutions accessible to most labs.
Get expert opinions and user perspectives on our genomic stability assays in the context of iPSC research.
Happening on Tuesday, November 14, 6 pm CET
Please enter your e-mail address.